Robert B Jenkins Selected Research

PCV regimen

5/2017

Genetic landscape of extreme responders with anaplastic oligodendroglioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert B Jenkins Research Topics

Disease

81	Neoplasms (Cancer) 01/2022 - 01/2002
33	Glioma (Gliomas) 01/2022 - 04/2002
30	Prostatic Neoplasms (Prostate Cancer) 10/2019 - 05/2002
24	Breast Neoplasms (Breast Cancer) 01/2020 - 06/2002
18	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2002
13	Neoplasm Metastasis (Metastasis) 11/2019 - 06/2002
9	Oligodendroglioma 01/2021 - 03/2003
8	Astrocytoma (Pilocytic Astrocytoma) 01/2022 - 07/2004
7	Disease Progression 05/2016 - 08/2002
5	Carcinogenesis 12/2015 - 11/2006
5	Carcinoma (Carcinomatosis) 09/2008 - 01/2002
4	Adenocarcinoma 02/2014 - 11/2006
3	Melanoma (Melanoma, Malignant) 07/2021 - 11/2005
3	Hypersensitivity (Allergy) 01/2018 - 09/2011
2	Central Nervous System Neoplasms 01/2022 - 03/2006
2	Microsatellite Instability 01/2021 - 11/2003
2	Brain Neoplasms (Brain Tumor) 11/2019 - 01/2019
2	Ganglioglioma 11/2019 - 11/2018
2	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 01/2011
2	Asthma (Bronchial Asthma) 01/2018 - 02/2016
2	Gliosarcoma 10/2017 - 11/2008
2	Diarrhea 04/2013 - 12/2008
2	Leukemia 12/2010 - 11/2009
2	Lipoma (Lipomata) 01/2010 - 08/2009
2	Sarcoma (Soft Tissue Sarcoma) 11/2008 - 05/2008
2	Atrophy 09/2008 - 11/2006
1	Infections 01/2022
1	Kidney Neoplasms (Kidney Cancer) 07/2021
1	Endometrial Neoplasms (Endometrial Cancer) 01/2021
1	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 01/2021
1	Birth Weight (Birth Weights) 01/2020

Drug/Important Bio-Agent (IBA)

27	Proteins (Proteins, Gene)FDA Link 11/2018 - 05/2002
15	RNA (Ribonucleic Acid)IBA 01/2021 - 07/2004
14	ErbB Receptors (EGF Receptor)IBA 03/2015 - 01/2002
13	Trastuzumab (Herceptin)FDA Link 01/2020 - 06/2002
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2006
12	Biological ProductsIBA 12/2017 - 05/2003
11	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 03/2006
11	ParaffinIBA 11/2019 - 05/2002
10	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 08/2002
9	AndrogensIBA 01/2019 - 07/2006
9	human ERBB2 proteinIBA 11/2018 - 12/2010
7	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2020 - 05/2002
6	Formaldehyde (Formol)FDA Link 11/2019 - 07/2004
6	Messenger RNA (mRNA)IBA 11/2017 - 04/2005
4	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022 - 01/2018
4	Estrogen ReceptorsIBA 07/2021 - 12/2010
4	Androgen Receptors (Androgen Receptor)IBA 02/2018 - 03/2014
4	Prostate-Specific Antigen (Semenogelase)IBA 01/2018 - 12/2014
4	Paclitaxel (Taxol)FDA LinkGeneric 04/2013 - 10/2005
3	Peptides (Polypeptides)IBA 11/2019 - 03/2014
3	telomerase RNA (bTR)IBA 12/2015 - 07/2014
3	Long Noncoding RNAIBA 12/2014 - 11/2013
3	Hormones (Hormone)IBA 10/2013 - 10/2010
2	AntigensIBA 01/2022 - 04/2005
2	Mitogen-Activated Protein KinasesIBA 01/2021 - 11/2019
2	Genetic Markers (Genetic Marker)IBA 01/2020 - 01/2018
2	Carboplatin (JM8)FDA LinkGeneric 01/2020 - 12/2005
2	Immunoglobulin E (IgE)IBA 01/2020 - 01/2018
2	Lapatinib (GW572016)FDA Link 01/2020 - 04/2013
2	Pharmaceutical PreparationsIBA 11/2019 - 07/2006
2	Vitamin D FDA LinkGeneric 05/2019 - 01/2018
2	Amyloid beta-PeptidesIBA 01/2019 - 01/2011
2	Phenobarbital (Luminal)FDA Link 12/2017 - 09/2008
2	UbiquitinIBA 01/2017 - 10/2015
2	CytokinesIBA 01/2017 - 10/2010
2	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 01/2016 - 06/2013
2	Shelterin ComplexIBA 12/2015 - 01/2015
2	Tumor Biomarkers (Tumor Markers)IBA 06/2015 - 04/2005
2	Vincristine (Oncovin)FDA LinkGeneric 03/2014 - 03/2006
2	Lomustine (CCNU)FDA Link 03/2014 - 03/2006
2	Procarbazine (Matulane)FDA Link 03/2014 - 03/2006
2	Indicators and Reagents (Reagents)IBA 03/2013 - 07/2005
2	temsirolimus FDA Link 10/2012 - 08/2005
2	Cyclin-Dependent Kinase Inhibitor p16IBA 07/2012 - 09/2010
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2010 - 01/2009
2	epidermal growth factor receptor VIIIIBA 12/2008 - 07/2004
2	ElementsIBA 05/2008 - 11/2005
2	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2006 - 10/2005
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2006 - 10/2005
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Viral AntigensIBA 01/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 12/2021
1	GenieIBA 01/2021
1	alpha-hydroxyglutarateIBA 11/2020
1	Oxidoreductases (Dehydrogenase)IBA 11/2020
1	C-Reactive ProteinIBA 01/2020
1	Docetaxel (Taxotere)FDA Link 01/2020
1	VitaminsIBA 01/2020

Therapy/Procedure

32	Therapeutics 01/2022 - 06/2002
16	Prostatectomy (Retropubic Prostatectomy) 11/2018 - 01/2002
14	Radiotherapy 01/2022 - 03/2003
14	Drug Therapy (Chemotherapy) 01/2021 - 03/2003
3	Castration 01/2019 - 03/2014
2	Immunotherapy 01/2021 - 02/2016
2	Ligation 10/2014 - 11/2005
2	Adjuvant Chemotherapy 12/2011 - 10/2005
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2021
1	Conformal Radiotherapy 01/2021